Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Supplemental material is available for this article. See also the editorial by Mesurolle and El Khoury in this issue.
These findings provide insight into the role of core beliefs about the self in the treatment of GAD.
This randomised trial of open masks versus a standard closed mask, demonstrates improved patient experience and equivalent setup accuracy supporting the adoption of open‑mask SGRT‑based immobilisation as a new patient centred...
E-cigarettes without further support were more effective than supportive messaging in helping people achieve sustained validated abstinence from smoking at 6 months.
Findings provide day-level support for a TPB-informed pathway linking within-person fluctuations in drinking attitudes to alcohol-related harm through drinking intentions and alcohol consumption.
A safety run-in with independent Data and Safety Monitoring Board review is planned during phase II to assess tolerance of the combination.
There was no change in HBV biomarkers and further development of cetrelimab for HBV was abandoned.
The initiation of antipsychotic therapy is a critical clinical window for early intervention to mitigate the long-term metabolic and psychiatric consequences of antipsychotic-induced weight gain.
Observed associations are small and of very low to low certainty, reflecting incomplete ultraviolet-exposure and risk-factor adjustment; causality cannot be established.
Chronotherapeutic environmental interventions were feasible and safe in ICU care. Feasibility results highlighted challenges related to ICU logistics, sedation-related assessment limitations and pandemic-related disruptions. The unexpectedly low delirium incidence limited conclusions regarding intervention efficacy.
These results suggest that dyspnea constitutes an important constraint on endurance performance during high-intensity running in healthy trained individuals, and identify acute L-menthol inhalation as an effective ergogenic...
Greater baseline total and partial EZ attenuation were associated with higher rates of GA growth and progressive EZ loss over time, establishing these EZ measures as important predictors of future GA growth and photoreceptor loss.
Further external validation is warranted, and additional clinical indicators are needed to predict disease activity.
Ocrelizumab treatment is associated with declining myo-inositol levels measured by MRS in both RMS and PPMS.
These data show that previous immune experience to earlier pandemic variants provided limited cross-protection and demonstrate that pemivibart increased protective titers against newly circulating SARS-CoV-2 in individuals...
Significant OS prolongation was observed in ITT population for LI + CIZ + SOC vs SOC, in LR and in ITT LR cN0, PD-L1TPS < 10% cohort having locally advanced squamous cell carcinoma tumors in oral cavity/soft-palate.
Bowel effects were low and comparable between groups, with moderate or big bowel problems reported by 2% (7/397) at baseline and 5% (12/265) for SBRT at 5 yr, and 2% (9/415) at baseline and 5% (13/253) for CRT at 5 yr.
A brief psychoeducational intervention significantly reduced psychological stress in dermatology outpatients.
78.3% of non-durable responders had ≥1 dose holds prompted by a platelet count of 250-400 × 10 9 /L, a platelet count that would not prompt a dose hold in real-world clinical practice.
In individuals with remitted psychotic depression, continuation treatment with sertraline plus olanzapine was associated with better outcomes in HRQOL domains directly relevant to mental health than treatment with sertraline...
The ML model supported the initial findings that a higher VL at baseline with an increasing CRP and decreasing ALC may help identify COVID-19 patients at high risk for hospitalization.
TRAC participants had less clinical decline at week 78, week 134, and EMBARK baseline than non-TRAC participants.
The refined CAB-based risk stratification identifies a UHR category in the IDEAL cohort, characterized by an increased risk of late recurrence up to 15 years from surgery, who may benefit from EET.
High-dose magnesium appeared safe with only a modest possible benefit of medical readiness for discharge at 12 h.
Older adults with gastric cancer achieved comparable oncologic outcomes to younger patients, despite more frequent treatment modifications and higher hematologic toxicity.
Adaptive designs were associated with higher primary endpoint success but not shorter primary completion time.
Although male patients had earlier clinical responses to bimekizumab treatment, female patients demonstrated longer-term improvements in composite and patient-reported outcomes.
At W24, patients showed greater improvement with dupilumab vs placebo in EREFS WOR total score (least squares mean difference [95% confidence interval] -2.17 [-2.59, -1.75], inflammatory subscore -1.65 [-1.96, -1.35], and...
At 1500 mg IV Q4W, a flat E-R relationship was observed between durvalumab PK exposure and safety endpoints including Grade 3 + treatment-related AEs, Grade 3 + treatment-related AEs of special interest, and AEs leading to...
DCA decreased plasma lactate -0.48 (0.82) mmol/L (-20%; P = 0.006).
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
